Synergistic Antibiotic Activity of Ricini Semen Extract with Oxacillin against Methicillin-Resistant Staphylococcus aureus
- PMID: 36830251
- PMCID: PMC9952580
- DOI: 10.3390/antibiotics12020340
Synergistic Antibiotic Activity of Ricini Semen Extract with Oxacillin against Methicillin-Resistant Staphylococcus aureus
Abstract
Resistant bacteria are emerging as a critical problem in the treatment of bacterial infections by neutralizing antibiotic activity. The development of new traditional mechanisms of antibiotics is not the optimal solution. A more reasonable approach may be to use relatively safe, plant-based compounds in combination with conventional antibiotics in an effort to increase their efficacy or restore their activity against resistant bacteria. We present our study of mixing Ricini Semen extract, or its constituent fatty acids, with oxacillin and testing the effects of each on the growth of methicillin-resistant Staphylococcus aureus. Changes in the cell membrane fluidity of methicillin-resistant S. aureus were found to be a major component of the mechanism of synergistic antibiotic activity of Ricini Semen extract and its constituent fatty acids. In our model, changes in cellular membrane fluidity disrupted the normal function of bacterial signaling membrane proteins BlaR1 and MecR1, which are known to detect oxacillin, and resulted in the incomplete expression of penicillin-binding proteins 2a and β-lactamase. Utilizing the mechanism presented in this study presents the possibility of developing a method for treating antibiotic-resistant bacteria using traditional antibiotics with plant-based compounds.
Keywords: Ricini Semen extract; membrane fluidity; methicillin-resistant Staphylococcus aureus; oxacillin; synergistic antibiotic activity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.Exp Biol Med (Maywood). 2017 Apr;242(7):731-743. doi: 10.1177/1535370216689828. Epub 2017 Jan 1. Exp Biol Med (Maywood). 2017. PMID: 28118725 Free PMC article.
-
A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA.Front Microbiol. 2024 Feb 1;14:1269392. doi: 10.3389/fmicb.2023.1269392. eCollection 2023. Front Microbiol. 2024. PMID: 38370578 Free PMC article.
-
Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus.J Biol Chem. 2020 Aug 7;295(32):10870-10884. doi: 10.1074/jbc.RA120.013029. Epub 2020 Jun 9. J Biol Chem. 2020. PMID: 32518158 Free PMC article.
-
Restoration of oxacillin susceptibility in methicillin-resistant Staphylococcus aureus by blocking the MecR1-mediated signaling pathway.J Chemother. 2006 Aug;18(4):360-5. doi: 10.1179/joc.2006.18.4.360. J Chemother. 2006. PMID: 17024790
-
The Cell Wall, Cell Membrane and Virulence Factors of Staphylococcus aureus and Their Role in Antibiotic Resistance.Microorganisms. 2023 Jan 19;11(2):259. doi: 10.3390/microorganisms11020259. Microorganisms. 2023. PMID: 36838224 Free PMC article. Review.
Cited by
-
Inhibition of (p)ppGpp Synthesis and Membrane Fluidity Modulation by Diosgenin: A Strategy to Suppress Staphylococcus aureus Persister Cells.Int J Mol Sci. 2025 Jun 30;26(13):6335. doi: 10.3390/ijms26136335. Int J Mol Sci. 2025. PMID: 40650109 Free PMC article.
-
Contemporary Insights into the Biological Mechanisms of Parkia biglobosa.Int J Environ Res Public Health. 2024 Mar 24;21(4):394. doi: 10.3390/ijerph21040394. Int J Environ Res Public Health. 2024. PMID: 38673307 Free PMC article. Review.
-
Enhanced Efficacy of Ciprofloxacin and Tobramycin against Staphylococcus aureus When Combined with Corydalis Tuber and Berberine through Efflux Pump Inhibition.Antibiotics (Basel). 2024 May 20;13(5):469. doi: 10.3390/antibiotics13050469. Antibiotics (Basel). 2024. PMID: 38786197 Free PMC article.
References
-
- Lee H., Yoon E.-J., Kim D., Jeong S.H., Won E.J., Shin J.H., Kim S.H., Shin J.H., Shin K.S., Kim Y.A. Antimicrobial Resistance of Major Clinical Pathogens in South Korea, May 2016 to April 2017: First one-year report from Kor-GLASS. Eurosurveillance. 2018;23:1800047. doi: 10.2807/1560-7917.ES.2018.23.42.1800047. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources